Kakuda, Nobuto Miyasaka, Tomohiro Iwasaki, Noriyuki Nirasawa, Takashi Wada-Kakuda, Satoko Takahashi-Fujigasaki, Junko Murayama, Shigeo Ihara, Yasuo Ikegawa, Masaya Additional file 1: Figure S1. of Distinct deposition of amyloid-β species in brains with Alzheimer’s disease pathology visualized with MALDI imaging mass spectrometry MALDI-IMS for SP free control subjects. Figure S2. IHC for Aβ40 (BA27) or Aβ42 (BC05) in brain with AD and CAA. Figure S3. MALDI-IMS of AD brain (No.3) merged on optic density figure. Figure S4. High resolution (20 μm) figure of MALDI-IMS for various C-terminal truncated Aβ in AD with severe CAA.Figure S5. MALDI-IMS for various N-terminal truncated and modified Aβs in AD with moderate CAA. Figure S6. MALDI-IMS for various N-terminal truncated and modified Aβs in AD with severe CAA. Figure S7. Anti-Aβ41 antibody characterization. Supplementary Table S1. (PDF 1494 kb) Amyloid β;Alzheimer’s disease;Cerebral amyloid angiopathy;Imaging mass spectrometry;C- and N-terminal variations of Aβ;Senile plaques;γ-secretase;Perivascular space 2017-10-16
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_1_Figure_S1_of_Distinct_deposition_of_amyloid-_species_in_brains_with_Alzheimer_s_disease_pathology_visualized_with_MALDI_imaging_mass_spectrometry/5504212
10.6084/m9.figshare.c.3905833_D1.v1